Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1

Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1

Through comparative genomics using PDX models of androgen-dependent (AD) and androgen-resistant (AR) tumors, Makino et al. identify opioid receptor kappa 1 (OPRK1) as being associated with castration-resistance. Loss of OPRK1 function delays castration-resistance and inhibits castration-resistant gr...

Full description

Bibliographic Details
Main Authors:	Yuki Makino, Yuki Kamiyama, J. B. Brown, Toshiya Tanaka, Ryusuke Murakami, Yuki Teramoto, Takayuki Goto, Shusuke Akamatsu, Naoki Terada, Takahiro Inoue, Tatsuhiko Kodama, Osamu Ogawa, Takashi Kobayashi
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-04-01
Series:	Communications Biology
Online Access:	https://doi.org/10.1038/s42003-022-03227-w

Similar Items

Author Correction: Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1
by: Yuki Makino, et al.
Published: (2022-07-01)

Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges
by: Yuki Kita, et al.
Published: (2018-09-01)

Identification of the α2 chain of interleukin‐13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient‐derived xenograft models
by: Takahiro Nagai, et al.
Published: (2023-02-01)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
by: Lin Hui-Ping, et al.
Published: (2011-08-01)

Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer
by: Yuki Teramoto, et al.
Published: (2021-09-01)

Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
by: Qin Feng, et al.
Published: (2019-09-01)

Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer
by: Sahyun Pak, et al.
Published: (2022-09-01)

Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer
by: Fuqiang Ban, et al.
Published: (2021-07-01)

GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer
by: Mohammad Amin Elahi Najafi, et al.
Published: (2023-09-01)

Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer.
by: Mark A Titus, et al.
Published: (2012-01-01)

Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7
by: Balaji Chandrasekaran, et al.
Published: (2023-03-01)

The Roles of Extracellular Vesicles in the Progression of Renal Cell Carcinoma and Their Potential for Future Clinical Application
by: Masashi Takeda, et al.
Published: (2023-05-01)

Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
by: Qiao-Hong Chen, et al.
Published: (2024-02-01)

Androgen receptor variants occur frequently in castration resistant prostate cancer metastases.
by: Xiaotun Zhang, et al.
Published: (2011-01-01)

Androgen receptor signaling and spatial chromatin organization in castration-resistant prostate cancer
by: Tianyi Zhou, et al.
Published: (2022-07-01)

Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer
by: Maria Massaro, et al.
Published: (2021-09-01)

NF-kappaB regulates androgen receptor expression and prostate cancer growth.
by: Zhang, L, et al.
Published: (2009)

Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer
by: Guiyang Jiang, et al.
Published: (2021-02-01)

Androgen receptor targeted therapies in metastatic castration-resistant prostate cancer – The urologists' perspective
by: Tan, J, et al.
Published: (2017)

Research Progress on the Mechanism of Androgen Receptor Signaling Pathway in Castration-Resistant Prostate Cancer
by: Na Cui, et al.
Published: (2023-11-01)

Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.
by: Steven Kregel, et al.
Published: (2013-01-01)

Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer.
by: Jae-Kyung Myung, et al.
Published: (2017-01-01)

Androgen receptor variant-7: an important predictive biomarker in castrate resistant prostate cancer
by: Oliver Sartor, et al.
Published: (2015-06-01)

The androgen receptor can signal through Wnt/β-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens
by: Lin Tai-An, et al.
Published: (2008-01-01)

The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.
by: Sharma, N, et al.
Published: (2013)

The androgen receptor induces a distinct transcriptional program in castration resistant prostate cancer in man
by: Sharma, N, et al.
Published: (2012)

Effect of Castration Methods on Gene Expression of Androgen Receptor Gene in Skeletal Muscles of Awassi Sheep
by: Alaa Kamil Abdulla, et al.
Published: (2015-12-01)

Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer
by: Shigetomo Yamada, et al.
Published: (2022-03-01)

Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer
by: Daisuke Obinata, et al.
Published: (2017-02-01)

Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer
by: Meng Wu, et al.
Published: (2023-01-01)

The Androgen Receptor and Its Crosstalk With the Src Kinase During Castrate-Resistant Prostate Cancer Progression
by: Lin Gao, et al.
Published: (2022-06-01)

Androgen Receptor Signaling and Metabolic and Cellular Plasticity During Progression to Castration Resistant Prostate Cancer
by: Takuma Uo, et al.
Published: (2020-10-01)

Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer
by: Yu Zhao, et al.
Published: (2016-04-01)

Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer.
by: Bin Gui, et al.
Published: (2017-01-01)

Androgen receptor inhibitors for non-metastatic castration-resistant prostate cancer: network meta-analysis
by: K. Mori, et al.
Published: (2020-11-01)

Nuclear receptor HNF4α promotes castration-resistant prostate cancer via its regulation of androgen receptor expression
by: WANG Zhu, ZHANG Ying, ZHANG Jianwen, DENG Qiong, LIANG Hui
Published: (2021-03-01)

Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?
by: Javier Pozas, et al.
Published: (2022-12-01)

Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling
by: Annelies Van Hemelryk, et al.
Published: (2022-11-01)

A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer
by: Katie Joanna Miller, et al.
Published: (2023-03-01)

Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer
by: Govindi J. Samaranayake, et al.
Published: (2017-10-01)